Literature DB >> 16544320

Cognitive impairment in neuromuscular disorders.

Maria Grazia D'Angelo1, Nereo Bresolin.   

Abstract

Several studies have suggested the presence of central nervous system involvement manifesting as cognitive impairment in diseases traditionally confined to the peripheral nervous system. The aim of this review is to highlight the character of clinical, genetic, neurofunctional, cognitive, and psychiatric deficits in neuromuscular disorders. A high correlation between cognitive features and cerebral protein expression or function is evident in Duchenne muscular dystrophy, myotonic dystrophy (Steinert disease), and mitochondrial encephalomyopathies; direct correlation between tissue-specific protein expression and cognitive deficits is still elusive in certain neuromuscular disorders presenting with or without a cerebral abnormality, such as congenital muscular dystrophies, congenital myopathies, amyotrophic lateral sclerosis, adult polyglucosan body disease, and limb-girdle muscular dystrophies. No clear cognitive deficits have been found in spinal muscular atrophy and facioscapulohumeral dystrophy.

Entities:  

Mesh:

Year:  2006        PMID: 16544320     DOI: 10.1002/mus.20535

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  22 in total

Review 1.  Non-coding RNAs in the nervous system.

Authors:  Mark F Mehler; John S Mattick
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

Review 2.  [Demyelinating disorders].

Authors:  T Weber; W Köhler
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

3.  White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Erin E Ward; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

Review 4.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17

5.  Excessive Daytime Sleepiness Is a Common Symptom in Fabry Disease.

Authors:  Thomas Duning; Michael Deppe; Simon Keller; Hagen Schiffbauer; Jörg Stypmann; Matthias Böntert; Roland Schaefer; Peter Young
Journal:  Case Rep Neurol       Date:  2009-07-22

6.  Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.

Authors:  Minati Singh
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599

7.  Diffusion tensor imaging reveals widespread white matter abnormalities in children and adolescents with myotonic dystrophy type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Christopher J Bell; Ryan L Muetzel; Kelvin O Lim; John W Day
Journal:  J Neurol       Date:  2012-11-29       Impact factor: 4.849

8.  Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up.

Authors:  Francesca Magri; Alessandra Govoni; Maria Grazia D'Angelo; Roberto Del Bo; Serena Ghezzi; Gandossini Sandra; Anna Carla Turconi; Monica Sciacco; Patrizia Ciscato; Andreina Bordoni; Silvana Tedeschi; Francesco Fortunato; Valeria Lucchini; Sara Bonato; Costanza Lamperti; Domenico Coviello; Yvan Torrente; Stefania Corti; Maurizio Moggio; Nereo Bresolin; Giacomo Pietro Comi
Journal:  J Neurol       Date:  2011-03-12       Impact factor: 4.849

9.  Motor neuron disease and frontotemporal dementia: One, two, or three diseases?

Authors:  Thomas H Bak
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

10.  Cognitive function and its relationship with brain structure in myotonic dystrophy type 1.

Authors:  Kathleen E Langbehn; Ellen van der Plas; David J Moser; Jeffrey D Long; Laurie Gutmann; Peggy C Nopoulos
Journal:  J Neurosci Res       Date:  2020-02-13       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.